PXL/HO/BEC-010/2020-21 Dt: 19.12.2020
Subject: Oncology Medicines procurement Tender by Buftea Obstetrics-Gynaecology Hospital, Romania
We are pleased to inform members that Pharmexcil is in receipt of communication from Embassy of India to Romania, Bucharest regarding procurement of Oncology medicines. The Buftea Obstetrics-gynecology Hospital at Buftea County, Romania, has listed a Framework Agreement for the acquisition of "PN Oncology Medicines" and issued a tender for procuring medicine. The details of the tender is given below:
Tender value: 11.155.639 RON (2,786,193 US dollars)
Last date of tender: 11.01.2021
Quotations are invited for a number of 56 PN Oncology medicines.
Some of the medicines for which large quantities are required include:
(i) Pembrolizumabum 50mg for an estimated sum of 2,920,654 RON
(ii) Nivolumabum 100mg for an estimated sum of 1,215,072 RON
(iii) Cetuximabum 5mg for an estimated sum of 1,088,445.00 RON
(iv) Trastuzumabum etamsinum 160mg for an estimated sum of 826,112.16 RON
(v) Pertuzumabum 420mg for an estimated sum of 806,313 RON
The members interested can directly contact with the organisation:
Buftea Obstertrics-Gynecology Hospital
Address: Studioului street, no. 5, Ilfov, Buftea County: Romania
Phone: +40 213515295
For more details members may also visit to their website/tender portal at https://e-licitatie.ro/pub/notices/c-notice/v2/view/100108953
Members may also contact the Commercial Wing of the Embassy of India, Bucharest for any further questions at email@example.com .
Members may please note that the above information is circulated on the basis of information received from Mr.Anup Demta, Second Secretary (Com & Cons), Embassy of India, Bucharest. Members are advised to make their own decisions before finalizing their business transactions.